Cefozopran: Difference between revisions
(Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443787193 | IUPAC_name = (6''R'',7''R'')-7-<nowiki>[</nowiki>[(2''Z'')-2-(5-amino-1,2,4-thiadi...") |
m (Protected "Cefozopran": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 4: | Line 4: | ||
| verifiedrevid = 443787193 | | verifiedrevid = 443787193 | ||
| IUPAC_name = (6''R'',7''R'')-7-<nowiki>[</nowiki>[(2''Z'')-2-(5-amino-1,2,4-thiadiazol-3-yl)- 2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-''f'']pyridazin- 4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | | IUPAC_name = (6''R'',7''R'')-7-<nowiki>[</nowiki>[(2''Z'')-2-(5-amino-1,2,4-thiadiazol-3-yl)- 2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-''f'']pyridazin- 4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | ||
| image = Cefozopran. | | image = Cefozopran.png | ||
| width = 280 | | width = 280 | ||
Line 74: | Line 74: | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 18:48, 18 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H17N9O5S2 |
Molar mass | 515.52 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Cefozopran |
Articles |
---|
Most recent articles on Cefozopran |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefozopran at Clinical Trials.gov Clinical Trials on Cefozopran at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefozopran
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefozopran Discussion groups on Cefozopran Patient Handouts on Cefozopran Directions to Hospitals Treating Cefozopran Risk calculators and risk factors for Cefozopran
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefozopran |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefozopran (INN) is a fourth-generation cephalosporin.
Spectrum of bacterial susceptibility and resistance
Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.[1]
References
- ↑ "Cefozopran Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Cephalosporin antibiotics
- Drug